MYBPC3 and cardiomyopathy: There were no significant differences between groups for presence of a pathogenic mutation in MYH7, MYBPC3, or TTN (29% vs. 39%, p = 1.00), or a first degree relative with cardiomyopathy (14% vs. 11%, p = 0.83) (Table 1).